Skip to main content
. 2021 Mar 18;11:6350. doi: 10.1038/s41598-021-85788-0

Figure 2.

Figure 2

Partial least squares-discriminate analysis (PLS-DA) plot of differential metabolites from control and COVID-19 patients and their corresponding VIP values. (a) PLSDA score plots for control (H-red), mild (M-green) and severe (S-blue) patients .VIP schematic scores of PLS-DA analysis for CvsMvsS (b), CvsM (c), CvsS (d), and MvsS (e) groups.